Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L. Levine, D. Gary Gilliland, Jan Cools et al.|Cancer Cell|2005Cited by 3k
Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518Jennifer Clark, D. Gary Gilliland|Blood|2004Cited by 80